The Combination of Rifampin Plus Moxifloxacin Is Synergistic for Suppression of Resistance but Antagonistic for Cell Kill of Mycobacterium Tuberculosis as Determined in a Hollow-Fiber Infection Model

mBio - United States
doi 10.1128/mbio.00139-10
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Society for Microbiology

Related search

Curing Mycobacterium Ulcerans Infection in Mice With a Combination of Rifampin-Streptomycin or Rifampin-Amikacin

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
2006English

Point-Of-Care System for Detection of Mycobacterium Tuberculosis and Rifampin Resistance in Sputum Samples

Journal of Clinical Microbiology
Microbiology
2013English

Copper Resistance Is Essential for Virulence of Mycobacterium Tuberculosis

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
2011English

Evaluation of the Genotype MTBDR Assay for Rapid Detection of Rifampin and Isoniazid Resistance in Mycobacterium Tuberculosis Isolates

Journal of Clinical Microbiology
Microbiology
2006English

Rifampin Plus Trimethoprim: Bactericidal Activity and Suppression of Resistance in Human Urine in Vitro.

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
1979English

High-Resolution Melting Curve Analysis for Rapid Detection of Rifampin and Isoniazid Resistance in Mycobacterium Tuberculosis Clinical Isolates

Journal of Clinical Microbiology
Microbiology
2010English

Extrapulmonary Dissemination of Mycobacterium Bovis but Not Mycobacterium Tuberculosis in a Bronchoscopic Rabbit Model of Cavitary Tuberculosis

Infection and Immunity
ParasitologyInfectious DiseasesImmunologyMicrobiology
2008English

Molecular Identification of Mycobacterium Tuberculosis and Analysis of Its Resistance to Rifampin in Sputa From Tuberculosis Suspected Patients

Atom Indonesia
RadiationNuclear MedicineRadiologyWaste ManagementNuclearNuclear EnergyHigh Energy PhysicsEngineeringImagingDisposal
2011English

Mycobacterium Marinum: A Potential Immunotherapy for Mycobacterium Tuberculosis Infection

Drug Design, Development and Therapy
Drug DiscoveryPharmacologyPharmaceutical Science
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy